Doctors in the U. S. now have another tool to fight a tough cancer. The FDA gave the green light for early use of an experimental pill called daraxonrasib. It targets pancreatic ductal adenocarcinoma, a fast-spreading form of pancreatic cancer that has already resisted other treatments. Patients who
Pancreatic cancer is one of the most lethal cancers in the United States, killing more than 50, 000 people each year. The disease is tough to treat and most patients die within a year of diagnosis, with only a small fraction surviving five years. Recently, two experimental drugs have entered clin
Arcellx’s share price has jumped sharply after Gilead Sciences announced a $7. 8 billion investment in the company’s partner drug, targeting a specific cancer type. The deal signals strong confidence from a major biotech player and lifts expectations for the drug’s future success. The partnership c
Japan is determined to speed up the availability of new cancer treatments. These treatments offer better outcomes than existing options. To make this happen, countries use special pathways to quicken the approval process. This is known as expedited approval. A study compared the speed of drug ap
Two big names in the medical world are teaming up to fight cancer. Bristol-Myers Squibb and BioNTech have struck a deal worth up to 11. 1 billion dollars. This is a huge amount of money. The deal is all about a new type of cancer treatment. This treatment uses the body's own immune system to fight
Colorectal cancer is a significant health issue in the United States, ranking as the second leading cause of cancer deaths. This year, over 150, 000 new cases are expected, with nearly 53, 000 fatalities. This is a stark reminder of the urgent need for effective prevention and treatment strategies
The financial impact of cancer treatments goes far beyond the cost of the drugs themselves. Side effects from these treatments can rack up significant bills, and if these costs are not accurately measured, it can skew the overall assessment of a treatment's value. The extra costs from side effe
In the world of cancer treatment, making the right call on which drugs to approve is a big deal. The National Institute for Health and Care Excellence, or NICE, is at the heart of this process. They often rely on a measure called overall survival, which tracks how long patients live after treatment.
Did you know that there's a compound called curcumin that could help in the fight against cancer? Curcumin is found in turmeric, a spice commonly used in cooking. Scientists are studying how it can be used to target a specific enzyme called Casein Kinase 2 (CK2), which plays a big role in how cells
Merck, a leading pharmaceutical company, shared its financial results for the third quarter of 2024, surprising some investors with better-than-expected earnings and revenue. The star of the show was Keytruda, their top-selling cancer drug, which continued to bring in strong sales. Newly launched tr
